 |
Nilofer Saba Azad | |
|---|---|
| Alma mater | Baylor College of Medicine |
| Scientific career | |
| Fields | Oncology |
| Institutions | Johns Hopkins University |
Nilofer Saba Azad is an American oncologist and physician-scientist specialized in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She is a professor at the Johns Hopkins School of Medicine and oversees clinical trials at the Sidney Kimmel Comprehensive Cancer Center.
Life
Azad earned a M.D. at Baylor College of Medicine in 2001. She completed a residency in internal medicine at Baylor in 2004 and a fellowship in oncology and hematology at the National Cancer Institute (NCI) in 2008. Azad was certified in medical oncology by the American Board of Internal Medicine in 2007. [1]
Azad joined the Sidney Kimmel Comprehensive Cancer Center (SKCCC) in 2008. She is a professor of oncology at Johns Hopkins School of Medicine. At the SKCCC, Azad serves as co-director of the Developmental Therapeutics Clinical Research Program and the Cancer Genetic and Epigenetic Core Research Program. [2] Azad specializes in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She researches the development of therapeutics and oversees clinical trials using epigenetic therapy, chemotherapy, and cancer immunotherapy. [1] She is a member of both the Epigenetics and Colon Cancer Stand Up 2 Cancer Dream Teams, serving as a Principal on the latter, and has held multiple leadership positions in national and international organizations. [2]
In September 2021, Azad was appointed by U.S. president Joe Biden to serve on the NCI National Cancer Advisory Board. [3] [2]
She speaks English and Hindustani. [1]
References
- ^ a b c "Nilofer Saba Azad, M.D., Professor of Oncology". Johns Hopkins Medicine. Retrieved 2021-09-22.
- ^
a
b
c
This article incorporates text from this source, which is in the
public domain:
"President Biden Appoints Members to National Cancer Advisory Board". The White House. 2021-09-15. Retrieved 2021-09-22.
- ^ "Two Johns Hopkins scientists named to National Cancer Advisory Board". The Hub. Johns Hopkins University. 2021-09-16. Retrieved 2021-09-22.
External links
- Nilofer Azad publications indexed by Google Scholar
- Nilofer Azad's publications indexed by the Scopus bibliographic database. (subscription required)
| Authority control databases: Academics |
|---|
- Living people
- Baylor College of Medicine alumni
- Johns Hopkins University faculty
- American cancer researchers
- 21st-century American women physicians
- 21st-century American physicians
- 21st-century American women scientists
- Physician-scientists
- American women medical researchers
- American women oncologists
- Biden administration personnel
|
Nilofer Saba Azad | |
|---|---|
| Alma mater | Baylor College of Medicine |
| Scientific career | |
| Fields | Oncology |
| Institutions | Johns Hopkins University |
Nilofer Saba Azad is an American oncologist and physician-scientist specialized in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She is a professor at the Johns Hopkins School of Medicine and oversees clinical trials at the Sidney Kimmel Comprehensive Cancer Center.
Life
Azad earned a M.D. at Baylor College of Medicine in 2001. She completed a residency in internal medicine at Baylor in 2004 and a fellowship in oncology and hematology at the National Cancer Institute (NCI) in 2008. Azad was certified in medical oncology by the American Board of Internal Medicine in 2007. [1]
Azad joined the Sidney Kimmel Comprehensive Cancer Center (SKCCC) in 2008. She is a professor of oncology at Johns Hopkins School of Medicine. At the SKCCC, Azad serves as co-director of the Developmental Therapeutics Clinical Research Program and the Cancer Genetic and Epigenetic Core Research Program. [2] Azad specializes in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She researches the development of therapeutics and oversees clinical trials using epigenetic therapy, chemotherapy, and cancer immunotherapy. [1] She is a member of both the Epigenetics and Colon Cancer Stand Up 2 Cancer Dream Teams, serving as a Principal on the latter, and has held multiple leadership positions in national and international organizations. [2]
In September 2021, Azad was appointed by U.S. president Joe Biden to serve on the NCI National Cancer Advisory Board. [3] [2]
She speaks English and Hindustani. [1]
References
- ^ a b c "Nilofer Saba Azad, M.D., Professor of Oncology". Johns Hopkins Medicine. Retrieved 2021-09-22.
- ^
a
b
c This article incorporates text from this source, which is in the
public domain:
"President Biden Appoints Members to National Cancer Advisory Board". The White House. 2021-09-15. Retrieved 2021-09-22.
- ^ "Two Johns Hopkins scientists named to National Cancer Advisory Board". The Hub. Johns Hopkins University. 2021-09-16. Retrieved 2021-09-22.
External links
- Nilofer Azad publications indexed by Google Scholar
- Nilofer Azad's publications indexed by the Scopus bibliographic database. (subscription required)
| Authority control databases: Academics |
|---|
- Living people
- Baylor College of Medicine alumni
- Johns Hopkins University faculty
- American cancer researchers
- 21st-century American women physicians
- 21st-century American physicians
- 21st-century American women scientists
- Physician-scientists
- American women medical researchers
- American women oncologists
- Biden administration personnel